An article in Leiden University’s Mare newspaper on 24 September states that the University Council advised against reappointing President of the Executive Board Annetje Ottow. The Board of Governors, deans and Annetje Ottow respond below.

An open academic culture, where quality beats quantity, where science and society are closely linked and where we recognise and reward everyone’s contribution is the aim of the university-wide Academia in Motion (AiM) programme.

Eric J. Snijder is professor of molecular Virology and head of the Section Research of the Department of Medical Microbiology of Leiden University Medical Center (LUMC). He is also a member of the Permanent Science Committee of LUMC and board member of the LUMC research profile area Immunology, Infection…

Alexander E. Gorbalenya is Professor of Medical Microbiology, in particular virus bioinformatics and Head of Virus Evolution and Bioinformatics lab in the Research Section. He is also visiting Professor at the Faculty of Bioengineering & Bioinformatics, Lomonosov Moscow State University, Moscow, Russia.…

Edmond H.H.M. Rings is professor of Pediatrics and chair of the department of Pediatrics at the Willem-Alexander Children’s hospital of the Leiden University Medical Center. He is also professor of Pediatrics and chair of the department of Pediatrics at the Sophia Children’s hospital of the Erasmus…

Leo Visser holds a position as Professor of Infection Diseases with specific interest in Travel Medicine. Leo Visser is head of the Department of Infectious Diseases and deputy director of Internal Medicine Residency Program at the Leiden University Medical Centre (LUMC). Leo Visser is Member of the…

Ed J. Kuijper is currently the head of the Experimental Microbiology and the Reference Laboratory for Clostridium difficile at the Leiden University Medical Centre and the Centre for Infectious Disease Control of the National Institute of Public Health. Since 2015, his department also hosts the 'National…

Professor Arjan Lankester is professor in Pediatrics and Pediatric Stem Cell Transplantation. He is also head of the JACIE-accrediated pediatric stem cell transplantation program, chair of the Working Party Inborn Errors of the European Society for Blood and Marrow Transplantation (EBMT) and chair of…

Jacques J.M. van Dongen is professor of Medical Immunology at Leiden University Medical Center (LUMC). Based on his 35-year experience in Medical Immunology at Erasmus MC, he was recruited to LUMC in 2016 to build an LUMC-wide immune monitoring program. He coordinated 7 European research networks in…

Hendrik Veelken is Professor of Internal Medicine, specifically Haematology, and chair of the Department of Haematology. He is director of the LUMC stem cell transplantation programme. In addition, he holds the function of chairman of the LUMC Oncology Centre.

Annemieke Geluk is professor of immunodiagnostics of mycobacterial infectious diseases, leprosy and tuberculosis. Additionally, her research group at the LUMC functions as the national reference centre for routine serological diagnosis of leprosy, and provides this service also in Europe.

Marlies Reinders is professor of Internal Medicine and since October 1st 2024 Member of the Board of Directors of Leiden University Medical Centre and Dean of the Faculty of Medicine at the University of Leiden.

Thorbald van Hall is professor experimental tumorimmunology at the Department of Medical Oncology in the LUMC. His expertise concerns resistance of tumors to immunotherapy.

Karin de Visser is professor in Experimental Immunobiology of Cancer (specifically of the tumor microenvironment) at Leiden University and affiliated with the department Immunohematology and Blood transfusion at Leiden University Medical Center. She is also senior group leader at the Division of Tumor…

Het Amerikaanse hooggerechtshof oordeelde op 1 juli dat een president tijdens hun ambtsperiode een zekere immuniteit heeft. Zij zijn onschendbaar in geval van ‘officiële handelingen’. Tessa van Buchem uit haar zorgen en kritiek in het FD.

Course, Worksop

The risk of a brain tumour recurring can be predicted more accurately by counting the number of immune cells in the tumour under a microscope. These are the findings from research conducted by LUMC, Erasmus MC and Heidelberg University.

People with relatively high levels of lipids in their blood are less likely to develop allergic conditions such as eczema and asthma. These lipids cause genes that play a key role in allergic reactions to be less active. Researchers from the Leiden University Medical Center (LUMC) have published an…

Fijs van Leeuwen is professor of radiology and chair of ‘molecular imaging and image guided therapy’. He also co-directs the LUMC-wide image-guided surgery program. In addition to his appointments at the LUMC he has guest-appointments at the Bionanotechnology group of Wageningen University, the departments…

Bart van Hoek, M.D., Ph.D. is Gastroenterologist –Hepatologist and Professor of Hepatology at Leiden University and Leiden University Medical Center, Leiden, The Netherlands. He is Medical Director of the Liver Transplant program -which he co-founded-and of the Hepatology Unit of the Dept. of Gastroenterology…

Hein W. Verspaget is professor in Biobanking at the Leiden University Medical Center (LUMC). Nowadays he is head of the centralized biobank facility in the LUMC, national and LUMC biobank-coordinator of the Parelsnoer Institute from the Netherlands Federation of University Medical Centres. He is also…

PhD defence

One in two people will be diagnosed with cancer. World Cancer Day on 4 February raises awareness of the impact of this devastating disease. Leiden University is conducting various studies aimed at preventing and controlling cancer. Below are just a few examples.

Researchers from Leiden have developed a promising TB vaccine that users can self-administer via a special patch. This could be beneficial for countries with limited health services, says PhD candidate Malene Neustrup.

ICT

From malaria parasites as a vaccine to how top-level bureaucrats reach their decisions: seven researchers from Leiden University have received a Vidi grant from the Dutch Research Council (NWO). This 800,000-euro grant will enable them to develop their own innovative line of research over the next five…

Researchers from the Leiden University Medical Center (LUMC) have successfully used stem cell gene therapy to treat a baby with the severe congenital immune disorder SCID. An important milestone: it is the first time stem cell gene therapy of Dutch origin has been administered to a patient, and also…